|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| OPERATING ACTIVITIES | |||||
| Net loss | |||||
| Adjustments to reconcile net loss to net cash used in operating activities: | |||||
| Amortization | |||||
| Stock Compensation | |||||
| Loss on prepaids | |||||
| Bad Debt | |||||
| Change in Operating Assets and Liabilities: | |||||
| Decrease (increase) in accounts receivable | |||||
| Decrease (increase) in deposits and prepaids | |||||
| Increase (decrease) in accounts payable and accrued expenses | |||||
| Increase (decrease) in accrued interest | |||||
| Net Cash Used in Operating Activities | |||||
| INVESTING ACTIVITIES | |||||
| Internal software development | |||||
| Website | |||||
| Patents | |||||
| Net cash provided by (used) in investing activities | |||||
| FINANCING ACTIVITIES | |||||
| Proceeds from sale of common stock issuance | |||||
| Proceeds from sale of common stock to be issued | |||||
| Proceeds from convertible debt | |||||
| Payment of convertible debt | |||||
| Proceeds from note payable-related party | |||||
| Net Cash Provided by Financing Activities | |||||
| Net Increase (Decrease) in Cash and Equivalents | |||||
| Cash and Equivalents at Beginning of the Period | |||||
| Cash and Equivalents at End of the Period | |||||
| SUPPLEMENTAL CASH FLOW INFORMATION | |||||
| Interest Paid | |||||
| NON-CASH DISCLOSURES | |||||
| Beneficial conversion feature | |||||
| Common stock issued for prepaid expense | |||||
| Common stock issued for convertible debt | |||||
Loading...